One highly multi-drug-resistant, mucus-producing and foul-smelling strain of Klebsiella ozaenae was isolated from a patient in the ICU of a Chinese tertiary hospital. MICs of several clinical antimicrobials against the strain were obtained using the Vitek-2 Compact System with AST-GN13 cards and resistance genes were evaluated by PCR and gene sequencing. The strain was resistant to most of the b-lactams and quinolones tested and carried several antibiotic resistance genes, including bla KPC-2 , bla TEM-98 , bla CTX-M-3 , bla SHV-26 and qnrS. To our knowledge, this is the first report of b-lactam and quinolone resistance genes co-existing in a K. ozaenae strain in China.
INTRODUCTION
Klebsiella ozaenae, a Gram-negative bacillus, is described as a respiratory tract and oral colonizer. It has been reported that K. ozaenae can cause invasive infections, including otitis media and mastoiditis, urinary tract infections, soft tissue infections and bacteraemia associated with neutropenia, pneumonia and meningitis (Goldstein et al., 1978) , and even mortality. K. ozaenae is naturally sensitive or intermediately sensitive to most antibiotics, such as cephalosporins, aminoglycosides, quinolones, tetracyclines and cotrimoxazole (Stock & Wiedemann, 2001 ). However, one highly multidrug-resistant strain of K. ozaenae was recently isolated from a 48-year-old male patient in the ICU of a Chinese hospital. In this study, we report the antibiotic-resistance phenotype and genetic characteristics of this strain.
METHODS
Bacterial strain identification. The K. ozaenae strain was isolated from the sputum specimen of a 48-year-old male patient in an ICU. The strain was identified by using the Vitek-2 Compact System with GNI cards, which was further confirmed by 16S rRNA gene sequencing. The biological characteristics of the strain were also assayed as part of the identification process.
Susceptibility testing. The MICs of clinical antimicrobials against the strain were obtained using the Vitek-2 Compact System with AST-GN13 cards. The results were interpreted according to the standards of the Clinical and Laboratory Standards Institute (CLSI). Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as controls.
b-lactamase determination. Klebsiella pneumoniae carbapenemase (KPC) production was determined by a Modified Hodge Test (MHT) with an ertapenem disk (10 mg, Oxoid) according to the guidelines of the CLSI. A KPC inhibition test was performed with an additional 10 ml phenylboronic acid (PBA, 300 mg l 21 ) added to the ertapenem disk (Pasteran et al., 2010) . Metallo-b-lactamase (MBL) production was evaluated by an imipenem/imipenem-EDTA combined-disk diffusion test (DDT) and an imipenem/EDTA double-disk synergy test (DDST) as described previously (Franklin et al., 2006; Kim et al., 2007) . Extended spectrum b-lactamase (ESBL) detection was performed according to CLSI guidelines. A zone of inhibition for cefotaxime/clavulanic-acid discs (Oxoid) 5 mm greater than cefotaxime discs (Oxoid) was interpreted as a positive result for ESBLs. Strains of K. pneumoniae, producing KPC-2, and Acinetobacter baumannii, expressing VIM-2, were used as positive controls and E. coli ATCC 25922 was used as a negative control.
PCR and amplified fragment sequencing. Genomic DNA for PCRs was prepared by using the boiling method. The presence of blactamase and quinolone-resistance-related genes, including bla KPC , bla VIM , bla IMP , bla SIM , bla GIM , bla SPM , bla OXA-23 , bla OXA-24 , bla OXA-58 , bla TEM , bla SHV , bla CTX-M-1 , bla CTX-M-2 , bla CTX-M-9 , qnrA, qnrB, qnrC, qnrD, qnrS, qepA, aac(6')-Ib-cr, gyrA, parC, and transferable element intI were determined by PCR. The PCR parameters used for all amplifications were as follows: an initial step at 94 uC for 3 min, followed by 30 cycles of 94 uC for 30 s, 56 uC for 30 s and 72 uC for 30 s, and a final elongation step at 72 uC for 5 min. The primers used (SBS Gentech) were described previously (Brisse et al., 1999; Ellington et al., 2007; Hata et al., 2005; Huang et al., 2009; Jeon et al., 2005; Koeleman et al., 2001; Labbate et al., 2009; Park et al., 2006; Tran et al., 2005; Walther-Rasmussen & Høiby, 2006; Wu et al., 2007; Zhou et al., 2007) . Other PCR components, including Taq polymerase, dNTPs and PCR buffer, were also provided by SBS Gentech. Amplified fragments were sequenced by Invitrogen (Shanghai) and Sangon Biotech and analysis was carried out using BLAST 
RESULTS

Strain identification
The strain, which was mucus-producing and foul-smelling, was identified as K. ozaenae by the Vitek-2 Compact System. About 1.4 kb of the 16S rRNA gene of this isolate was amplified and sequenced; it shared 99 % sequence similarity with K. ozaenae ATCC 11296. Based on its biological and biochemical characteristics and the results of 16S rRNA gene sequencing, the isolate was confirmed as K. ozaenae.
Antibiotic susceptibility
The strain of K. ozaenae isolated in this study was resistant to most of the clinical antimicrobials tested, including imipenem, ertapenem, ampicillin/sulbactam, piperacillintazobactam, aztreonam, ceftazidime, cefepime, levofloxacin and ciprofloxacin, but it was sensitive to gentamicin with an MIC¡1 mg ml
21
. The MICs obtained using the Vitek-2 compact system with AST-GN13 cards are shown in Table 1 .
Phenotype detection of b-lactamase
In the MHT, a strong positive result was obtained. But in KPC inhibition tests, no positive result was observed, although this b-lactamase was inhibited by the addition of PBA. The strain was positive for the ESBL phenotype in screening but no positive result was discovered from the DDT and DDST.
Antibiotic resistance genes A~950 bp amplified fragment was obtained by PCR that was 100 % identical to the partial sequence of the K. pneumoniae plasmid bla KPC-2 gene (GenBank accession no. EU594576), according to sequence analysis. Another three b-lactamase-encoding genes were identified, which shared the same deduced amino sequences as TEM-98, SHV-26 and CTX-M-3. For the quinolone-resistance-related genes, the strain was positive for qnrS, aac(69)-Ib, gyrA and parC genes. No nucleotide acid mutations in the qnrS and aac(69)-Ib genes were found compared with the published sequences (GenBank nos AB187515 and AF479774). Compared with the corresponding sequence of E. coli, no amino acid substitutions were found coded in the gyrA and parC gene sequences (Brisse et al., 1999 ). An intI gene fragment of expected size was obtained by PCR but PCRs were negative for the following antibiotic-resistance genes: bla VIM , bla IMP , bla SIM , bla GIM , bla SPM , bla OXA-23 , bla OXA-24 , bla OXA-58 , bla CTX-M-2 , bla CTX-M-9 , qnrA, qnrB, qnrC, qnrD and qepA.
DISCUSSION
K. ozaenae has been described as a respiratory tract and oral colonizer (Goldstein et al., 1978) . The strain of K. ozaenae that was isolated from the sputum specimen of a 48-year-old male patient was mucus-producing and foulsmelling. This K. ozaenae isolate was resistant to most cephalosporins, including cefotetan, cefazolin, ceftriaxone, ceftazidime and cefepime with MICs of 16, ¢64, ¢64, ¢64 and 16 mg ml 21 , respectively. The strain had an ESBL-positive phenotype with TEM-, SHV-and CTX-M-type b-lactamase-encoding genes detected by PCR. According to the sequence analysis, these genes were bla TEM-98 , bla SHV-26 and bla CTX-M-3 , respectively, which was in agreement with previous reports (Huang et al., 2009 ). The presence of ESBL genes in such strains may pose a threat to this class of antibiotic.
The strain of K. ozaenae investigated in this study expressed resistance to imipenem and ertapenem (MICs ¢16 and ¢8 mg ml 21 , respectively). The MHT resulted in the detection of a KPC phenotype, which could be inhibited by the addition of PBA. MBL screening was negative both in DDTs and DDSTs. These results strongly indicated that this isolate produced KPC-type b-lactamases. The strain was tested for the presence of carbapenemase-encoding genes, including bla KPC , bla VIM , bla IPM , bla GIM , bla SIM , bla SPM , bla OXA-23 , bla OXA-24 and bla OXA-58 , all of which gave negative results by PCR except for the bla KPC gene, which was positive. According to sequence analysis, this gene shared 100 % sequence similarity with the K. pneumoniae bla KPC-2 gene (GenBank no. EU594576). A previous study reported that the bla KPC-2 gene is located within a 10 kb transposon named Tn4401 on a plasmid of K. pneumoniae (Naas et al., 2008) . Whether the bla KPC-2 gene of K. ozaenae is plasmid-borne requires further investigation.
The MICs of levofloxacin, liprofloxacin for this strain, obtained using the Vitek-2 compact system with GN13 Table 1 . MICs of various antimicrobials against a highly multi-drug-resistant strain of K. ozaenae
The antimicrobial susceptibility tests were performed with the Vitek 2 compact system, using AST-GN13 cards (bioMérieux). The results were interpreted according to CLSI guidelines. Amp, ampicillin, Sam, ampicillin/sulbactam; Amk, amikacin; Azm, aztreonam; Tms, trimethoprimsulfamethoxazole; Ctn, cefotetan; Cax, ceftriaxone; Cfz, cefazolin; Cpe, cefepime; Caz, ceftazidime; Gm, gentamicin; To, tobramycin; Lvx, levofloxacin; Cp, ciprofloxacin; Imp, imipenem; Etp, ertapenem; Ptz, piperacillin 
cards, were ¢4 and ¢8 mg ml
21
, respectively. Quinolone resistance normally arises by mutations in the chromosomal genes for DNA gyrase and type IV topoisomerases (Brisse et al., 1999; Tran et al., 2005) but no mutations were detected in the quinolone resistance-determining regions of the gyrA and parC genes. Plasmid-mediated quinolone resistance genes, including qnrA, qnrB, qnrC, qnrD, qnrS, qepA and aac(69)-Ib-cr, were evaluated using PCR and sequence analysis. Amplified fragments of qnrS and aac(69)-Ib genes were obtained, which shared 100 % sequence similarity with those of previous reports (Hata et al., 2005; Park et al., 2006; GenBank nos. AB187515 and AF479774, respectively) . QnrS showed 59 % deduced amino acid similarity with Qnr and the resistance-encoding activity of the qnrS gene was similar to that of the qnr gene, preventing quinolone inhibition due to DNA gyrase alterations (Hata et al., 2005; Tran et al., 2005) . The aac(69)-Ib-cr gene is reported to encode a ciprofloxacin-modifying enzyme (Park et al., 2006) , but no cr variant, responsible for low-level ciprofloxacin resistance, was found in this isolate.
Cephalosporins, carbapenems and quinolones are frequently used in anti-infection therapy in our hospital. This strain of K. ozaenae showed no sensitivity to several antibiotics. Five antimicrobial resistance-associated genes were discovered in this strain, including bla KPC-2 , bla TEM-98 , bla CTX-M-3 , bla SHV-26 and qnrS, most of which are reported to be plasmid-borne (Huang et al., 2009; Jeon et al., 2005; Naas et al., 2008; Walther-Rasmussen & Høiby, 2006; Wu et al., 2007) . As such, it may be critical for us to intensify surveillance to reduce the risk of nosocomial cross infection.
Meanwhile, this strain of K. ozaenae was positive for the intI gene. Class I integrons encoded by this gene contain a site-specific recombination system that is capable of integrating and expressing genes and represents a major reservoir of antibiotic-resistance genes (Labbate et al., 2009) . This may play an important role in acquisition of the multi-drug resistance genes.
